Research

Recording COVID-19 consultations: review of symptoms, risk factors, and proposed SNOMED CT terms

Bhautesh Dinesh Jani, Jill P Pell, Dylan McGagh, Harshana Liyanage, Dave Kelly, Simon de Lusignan, Christopher J Weatherburn, Ronnie Burns, Frank M Sullivan and Frances S Mair
BJGP Open 2020; 4 (4): bjgpopen20X101125. DOI: https://doi.org/10.3399/bjgpopen20X101125

Abstract

Background There is an urgent need for epidemiological research in primary care to develop risk assessment processes for patients presenting with COVID-19, but lack of a standardised approach to data collection is a significant barrier to implementation.

Aim To collate a list of relevant symptoms, assessment items, demographics, and lifestyle and health conditions associated with COVID-19, and match these data items with corresponding SNOMED CT clinical terms to support the development and implementation of consultation templates.

Design & setting Published and preprint literature for systematic reviews, meta-analyses, and clinical guidelines describing the symptoms, assessment items, demographics, and/or lifestyle and health conditions associated with COVID-19 and its complications were reviewed. Corresponding clinical concepts from SNOMED CT, a widely used structured clinical vocabulary for electronic primary care health records, were identified.

Method Guidelines and published and unpublished reviews (N = 61) were utilised to collate a list of relevant data items for COVID-19 consultations. The NHS Digital SNOMED CT Browser was used to identify concept and descriptive identifiers. Key implementation challenges were conceptualised through a Normalisation Process Theory (NPT) lens.

Results In total, 32 symptoms, eight demographic and lifestyle features, 25 health conditions, and 20 assessment items relevant to COVID-19 were identified, with proposed corresponding SNOMED CT concepts. These data items can be adapted into a consultation template for COVID-19. Key implementation challenges include: 1) engaging with key stakeholders to achieve ’buy in’; and 2) ensuring any template is usable within practice settings.

Conclusion Consultation templates for COVID-19 are needed to standardise data collection, facilitate research and learning, and potentially improve quality of care for COVID-19.

How this fits in

Recording of clinical features of COVID-19 presentation in primary care is likely to be poor in the absence of a template. A rapid literature review was therefore conducted to collate a comprehensive list of symptoms, assessment items, demographics, and lifestyle and health conditions associated with COVID-19, with proposed corresponding SNOMED CT clinical terms. The evidence base around COVID-19 is rapidly evolving and this list may have to be updated in the future as new evidence becomes available. These data items can be adapted into a consultation template to standardise data collection, which in turn can facilitate research and improve quality of record keeping. In practice, there are often multiple SNOMED CT clinical terms for recording a single data item. A professional consensus will be needed among clinician users to agree on appropriate SNOMED CT clinical terms to be used in a template. Implementation and widespread use of a COVID-19 consultation template will need positive engagement with key stakeholders.

Introduction

The COVID-19 pandemic is an unprecedented global health challenge. Understanding of the epidemiology and clinical features of COVID-19 is rapidly evolving. New evidence is constantly emerging, with articles being published or uploaded on preprint servers regularly and various public health bodies, nationally and internationally, releasing their respective guidelines.

COVID-19 consultations in primary care are further complicated by contextual factors. In the UK, most of the consultations for patients with COVID-19 related symptoms are conducted remotely.1–3 This usually involves more than one screen being used at the same time, which makes it challenging for GPs to accurately recall and record all relevant clinical features during their consultation with patients with suspected COVID-19 symptoms. When the consultation is in-person in the surgery, personal protective equipment (PPE) restricts normal recording patterns, and this is even worse during home visits.

Good quality epidemiological studies are urgently needed to understand COVID-19.4 Most of the epidemiological studies until now have been conducted in secondary care.5 There is an urgent need for high-quality primary care epidemiological studies for COVID-19. Recently, the use of COVID-19 specific codes have been recommended but these codes mainly cover process measures and diagnostic terms, not clinical presentation features such as symptoms and assessment.6,7 Previous research has suggested that only 37% of clinical problems were coded in primary care records.8 Underreporting of relevant clinical features for COVID-19 in primary care is likely during COVID-19 related consultations, which will be a significant hindrance for high quality primary care research. A computerised, condition-specific template has previously been shown to improve the quality of care and recording in primary care, and it could be implemented for COVID-19.9

The aim of this study was to collate a list of relevant symptoms, assessment items, demographics, and lifestyle and health conditions associated with COVID-19 and its complications, and match these data items with proposed examples of corresponding SNOMED CT clinical terms, which will support the development and implementation of primary care consultation templates. The clinical utility of any template developed based on this work will be to help clinicians record consultations for patients presenting with suspected COVID-19 related symptoms in primary care.

Method

The review of clinical terms involved three distinct stages: 1) search of clinical guidelines, and published and preprint literature to collate the list of relevant clinical data items for COVID-19 consultation; 2) identify examples of corresponding SNOMED CT codes that map to the identified clinical data items; and 3) conceptualise implementation challenges through an NPT lens.

Search for clinical data items for COVID-19

The authors searched PubMed, the preprint server medRxiv, and centre for evidence-based medicine websites for reviews using ’COVID-19‘ as a keyword on 14 May 2020. The PubMed search resulted in 963 articles, while 548 articles were found on preprint server medRxiv. The inclusion criteria were systematic reviews and meta-analyses relating to symptoms, sociodemographic and lifestyle factors, past medical history, and assessment of COVID-19 . As the focus was related to primary care assessment, reviews relating to blood tests and imaging for COVID-19 were excluded. Twenty-one systematic reviews on preprint servers and 24 published systematic reviews from PubMed were identified. The authors searched for COVID-19 related guidelines on Public Health England, Health Protection Scotland, Public Health Wales, British Medical Journal (BMJ), Royal College of General Practitioners (RCGP), National Institute for Health and Care Excellence (NICE), and World Health Organization (WHO) websites. Sixteen clinical guidelines were considered for collating the list of COVID-19 consultation data items described above.

Search for corresponding clinical terms for COVID-19

SNOMED CT is the most comprehensive structured clinical terminology in use around the world and can be used in electronic health records (http://www.snomed.org/snomed-ct/why-snomed-ct). This international clinical terminology has been implemented across various health and care settings, including primary and secondary care. Principles outlined in Data Quality Guidance: Transitioning from Read to SNOMED CT by NHS Digital were used for choosing examples of proposed SNOMED CT clinical terms.10 First, the authors referred to appropriate SNOMED hierarchies, for example, ‘disorders’ or ‘situation’ for recording health conditions, and ‘finding’ or ‘observable entity’ for recording symptoms and signs. Only SNOMED CT codes that had equivalent Read codes were considered, as Read codes are still in use in general practice in Scotland. Codes that were regarded as ‘inactive’ and no longer in use were also excluded. SNOMED CT UK edition (version 20200415) was interrogated by the NHS Digital web browser to search for terms and identifiers for each of the clinical data items identified from the previous step. Additionally, the SNOMED CT code identified was matched to the corresponding Read version 2 codes using NHS Digital browser.11 https://hscic.kahootz.com/connect.ti/t_c_home/viewdatastore?dsid=407588&adv=S&showAllColumns=N&datViewMode=list&showSingleItem=N&cardColNo=

Conceptualising implementation of consultation template

GP consultation templates are often viewed as less patient-centred and potentially disruptive to communication.12 The majority of existing consultation templates are used for management of long-term conditions; however, they have also been used for recording management of acute infections.13 Widespread adaptation of a template in a short timeframe can provide significant implementation challenges. An NPT lens was used to conceptualise these challenges and corresponding key strategies to deal with those challenges.14

Results

Clinical data items and SNOMED CT codes

In total, searches identified 32 symptoms associated with COVID-19 presentation from 10 guidelines,1,3,15–22 13 published reviews,23–35 and 12 preprint reviews.36–47 See Table 1 for the list of symptoms and proposed corresponding SNOMED CT codes. The symptoms of COVID-19 were heterogenous in nature and included flu-like; respiratory; gastrointestinal; central nervous system; ear, nose, and throat; and eye symptoms reported in the literature.

View this table:
Table 1. Symptoms and assessment items relevant for COVID-19 primary care consultation with respective SNOMED CT concept identifiers

The clinical domain of primary care assessment for COVID-19 had the least number of supporting reviews (two preprint reviews)39,48 and the majority of the data items included were on the basis of clinical guidelines,1–3,16–20,49,50 which in turn were based on expert opinions (Table 1). The data items included for COVID-19 assessment were based on data items validated for general practice consultations, but not specifically for COVID-19 (for example, telephone consultation for suspected sepsis49 and use of the NEWS2 tool1).

Demographic factors (age, sex, and ethnicity) were reported to be relevant for COVID-19 susceptibility and complications by two guidelines,15,20 10 published reviews,5,25,26,28,30,33,51–54 and seven preprint reviews.37,43,55–59 Lifestyle factors (working, smoking, and body mass index) were reported to be relevant for COVID-19 related assessment by two guidelines,15,20 one published review,51 and seven preprint reviews.37,43,55–57,59,60 Individuals working in the health profession were regarded as high risk by one guideline.20 See Table 2 for the list of relevant demographics and lifestyle factors, and examples of corresponding SNOMED CT codes (apart from clinical terms for age and sex, which are usually recorded in all primary care records).

View this table:
Table 2. Demographic, lifestyle, and existing health conditions relevant for COVID-19 primary care consultations

In total, 25 health conditions were identified with COVID-19 vulnerability and/or complications, reported by two guidelines,15,20 16 published reviews5,25–28,30–33,54,61–66 and 10 preprint reviews.37,39,42,45,47,57,59,60,67,68 The list of conditions included the ’high-risk‘ or ’extremely vulnerable from COVID-19’ criteria based on guidelines issued by Public Health England and Health Protection Scotland.69,70 The list included a breadth of conditions ranging from cardiovascular, respiratory, immunosuppressed conditions, and previous cancer (see Table 2 for the list of medical conditions and the proposed examples of corresponding SNOMED CT codes). The mapping Read version 2 codes for the SNOMED CT codes identified are listed in Supplementary file Tables S1-4.

Implementation challenges and solutions

There is an extensive literature regarding barriers and facilitators to digital health implementation.71 This literature has demonstrated the importance of considering implementation issues whenever introducing any new digital health system, including those relating to electronic medical record systems.72 While electronic medical record systems are fully integrated within general practice in the UK, changes to functionality or uptake and utilisation of new templates within electronic medical record systems may not become widespread unless potential barriers or facilitators to use are considered.73 NPT is a theory of implementation that has been used extensively over the last decade to understand how new service innovations, particularly digital health innovations, can become embedded and implemented, or not, as part of routine practice.14 It suggests the need to consider issues relating to: coherence, how people make sense of a new way of working; cognitive participation, the engagement work required to get people to ’buy into‘ adopting a new way of working; collective action, the work of operationalising a new digital tool; and reflexive monitoring, the work of appraising, judging, or adapting a new digital innovation. There is evidence that considering and addressing such issues at the start of any new digital intervention will enhance the likelihood of routine embedding as part of normal practice. Table 3 outlines key issues that should be addressed in order to enhance uptake and utilisation of any new COVID-19 template. As a proof of concept, a COVID-19 consultation template prototype using data items relevant for symptoms and assessment was developed at a practice level in EMIS (Figure 1). Such consultation template prototypes may have to be modified after operationalisation, based on user feedback.

View this table:
Table 3. Key Normalisation Process Theory-informed implementation issues to consider when introducing a new COVID-19 template
Figure 1.
Figure 1. A consultation template prototype in EMIS with symptoms and assessment items for recording COVID-19 consultations in primary care

Discussion

The authors identified 32 symptoms, 20 assessment items, eight demographic and lifestyle features, and 25 health conditions relevant for recording in COVID-19 primary care consultations. The supporting evidence base for these data items comprised of 16 clinical guidelines, 24 published, and 21 unpublished systematic reviews. The authors propose examples of corresponding clinical terms for all clinical data items from the SNOMED CT browser, which can be used to develop consultation templates for different primary care IT system providers. The authors also discuss the likely implementation challenges and potential solutions for large scale roll out of a COVID-19 consultation template. The contents of any COVID-19 consultation template may have to be adapted in future as knowledge and understanding evolves.

Strengths and limitations

This is the first study to collate a list of relevant clinical items and corresponding clinical terms for COVID-19 consultation. The search for preprint servers enabled the authors to include the most up-to-date evidence, with the caveat that these platforms publish rapid non-peer reviewed literature. This study also outlines an implementation blueprint using a well-known theoretical framework for complex interventions.

There are several limitations. First, the authors did not employ a systematic search strategy for the literature review, and did not conduct a quality appraisal of the included studies as these were not the objectives of this study. The study objective was to facilitate standardised data collection, which in turn can lead to high quality research and strengthen the evidence base. Several data items were included from preprint studies that have not undergone the scrutiny of peer review, and future evidence may suggest that recording of these data items is not necessary for risk assessment in primary care.

Comparison with existing literature

Implementation of a COVID-19 consultation template is likely to face similar challenges to those observed with implementation of other general practice consultation templates. The previous positive experiences with the use of a template have included providing a structured consultation and being more comprehensive, while the use of a template has also been perceived as less patient-centred and more focused on a biomedical agenda.12,74,75 The uptake of a template in clinical practice is not likely to be universal; clinicians may need prompting and the template may require reinforcing to improve utilisation.13 There have been very few primary care-based studies of COVID-19, and these studies have not been able to report on symptoms or assessment due to inconsistencies in recording of symptoms in primary care.76,77

Implications for research and practice

The list of clinical terms can lead to the development of COVID-19 consultation templates, which in turn will help with standardised data collection and high quality research. A consultation template can potentially help with quality of clinical care and record keeping by facilitating comprehensive coverage of various clinical domains relevant to COVID-19.78 The use of a consultation template along with coding of other process measures included in the recently published ontology79 https://bioportal.bioontology.org/ontologies/COVID19/?p=summary and SNOMED CT codes on COVID-19 released by NHS Digital80 https://hscic.kahootz.com/connect.ti/COVID19_info_sharing/view?objectId=67227941can also help with disease surveillance. Several data items related to demographics, lifestyle, and past medical history may already be recorded in patient’s existing primary care records. These items are still included in the template as they will be relevant in out-of-hours settings where this information may not be readily available. The authors acknowledge that the codes presented are only examples for recording the relevant clinical data items. In practice, there are often multiple ways of recording a single data item and previous research has suggested evidence of considerable heterogeneity in SNOMED CT coding.81,82 A professional consensus exercise will be needed among clinician users to agree on appropriate SNOMED CT clinical terms. The use of a COVID-19 consultation template has the potential to offer consistency in data collection, albeit with some variations in codes used to record clinical data items.

Notes

Funding

There are no funders to report for this article.

SdeL is Director of the Royal College of General Practitioners, Research and Surveillance Centre (English national surveillance system). SdeL has received commercial funding for investigator led research, and belongs to advisory boards, but not related to COVID-19 and all through his university.

Ethical approval

No ethical approval was required.

Provenance

Freely submitted; externally peer reviewed.

Acknowledgements

  • Received May 29, 2020.
  • Accepted July 10, 2020.

This article is Open Access: CC BY license (https://creativecommons.org/licenses/by/4.0/)

References

  1. 1.↵
    1. National Institute for Health and Care Excellence
    (2020) COVID-19 rapid guideline: managing suspected or confirmed pneumonia in adults in the community. NG165. 13 Aug 2020. https://www.nice.org.uk/guidance/ng165.
  2. 2.
    1. Greenhalgh T,
    2. Koh GCH,
    3. Car J
    (2020) Covid-19: a remote assessment in primary care. BMJ 368:doi:10.1136/bmj.m1182, pmid:32213507. m1182.
    OpenUrlFREE Full Text
  3. 3.↵
    1. Royal College of General Practitioners
    (2020) Guide to triaging patients with potential symptoms. 13 Aug 2020. https://elearning.rcgp.org.uk/mod/page/view.php?id=10704.
  4. 4.↵
    1. Lipsitch M,
    2. Swerdlow DL,
    3. Finelli L
    (2020) Defining the epidemiology of Covid-19 — studies needed. N Engl J Med 382(13):1194–1196, doi:10.1056/NEJMp2002125, pmid:32074416.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Wynants L,
    2. Van Calster B,
    3. Collins GS,
    4. et al.
    (2020) Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal. BMJ 369, doi:10.1136/bmj.m1328, pmid:http://www.ncbi.nlm.nih.gov/pubmed/32265220. m1328.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. de Lusignan S,
    2. Williams J
    (2020) To monitor the COVID-19 pandemic we need better quality primary care data. BJGP Open 4(2), doi:10.3399/bjgpopen20X101070, pmid:http://www.ncbi.nlm.nih.gov/pubmed/32295793. bjgpopen20X101070.
    OpenUrlFREE Full Text
  7. 7.↵
    1. Faculty of Clinical Informatics
    (2020) COVID-19 coding in primary care. 13 Aug 2020. https://facultyofclinicalinformatics.org.uk/web/content/1607?unique=425692a55f2018b717232f96407b66f158c6d52c&download=true.
  8. 8.↵
    1. Salisbury C,
    2. Procter S,
    3. Stewart K,
    4. et al.
    (2013) The content of general practice consultations: cross-sectional study based on video recordings. Br J Gen Pract 63(616):e751–e759, doi:10.3399/bjgp13X674431, pmid:http://www.ncbi.nlm.nih.gov/pubmed/24267858.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Fung CH
    (2006) Computerized condition-specific templates for improving care of geriatric syndromes in a primary care setting. J Gen Intern Med 21(9):989–994, doi:10.1007/BF02743150, pmid:http://www.ncbi.nlm.nih.gov/pubmed/16918747.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. NHS Digital
    (2019) Data Quality Guidance: transitioning from Read to SNOMED CT. Version 5. 13 Aug 2020. https://hscic.kahootz.com/gf2.ti/f/762498/54542725.1/DOCX/-/Data_Quality_Guidance_for_Primary_Care_v2.docx.
  11. 11.↵
  12. 12.↵
    1. Swinglehurst D,
    2. Greenhalgh T,
    3. Roberts C
    (2012) Computer templates in chronic disease management: ethnographic case study in general practice. BMJ Open 2(6), doi:10.1136/bmjopen-2012-001754, pmid:http://www.ncbi.nlm.nih.gov/pubmed/23192245. e001754.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Chen C,
    2. Crowley R
    (2019) Improving assessment of children with suspected respiratory tract infection in general practice. BMJ Open Qual 8(2):e000450, doi:10.1136/bmjoq-2018-000450, pmid:http://www.ncbi.nlm.nih.gov/pubmed/31206053.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. May CR,
    2. Cummings A,
    3. Girling M,
    4. et al.
    (2018) Using Normalization Process Theory in feasibility studies and process evaluations of complex healthcare interventions: a systematic review. Implement Sci 13(1):80, doi:10.1186/s13012-018-0758-1, pmid:29879986.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. BMJ Best Practice
    (2020) Coronavirus disease 2019 (COVID-19). 13 Aug 2020. https://bestpractice.bmj.com/topics/en-gb/3000168.
  16. 16.↵
  17. 17.
    1. Public Health Wales
    (2020) (COVID-19) INTERIM guidance for primary care management of patients presenting to primary care. 13 Aug 2020. https://phw.nhs.wales/topics/latest-information-on-novel-coronavirus-covid-19/information-for-healthcare-workers-in-wales/180320-interim-primary-care-guidance-covid19.
  18. 18.
    1. Razai MS,
    2. Doerholt K,
    3. Ladhani S,
    4. et al.
    (2020) Coronavirus disease 2019 (covid-19): a guide for UK GPs. BMJ 368:doi:10.1136/bmj.m800, pmid:32144127. m800.
    OpenUrlFREE Full Text
  19. 19.
  20. 20.↵
    1. World Health Organization,
    2. International Severe Acute Respiratory and Emerging Infection Consortium
    (2020) Case record form instructions: severe acute respiratory infection clinical characterisation data tools. 13 Aug 2020. https://media.tghn.org/medialibrary/2016/06/ISARIC-WHO-SARI_Case_Record_Form_7JAN16.pdf.
  21. 21.
    1. Healthcare Improvement Scotland
    (2020) Assessment of COVID-19 in primary care. 13 Aug 2020. https://www.sign.ac.uk/our-guidelines/assessment-of-covid-19-in-primary-care/.
  22. 22.↵
    1. Struyf T,
    2. Deeks JJ,
    3. Dinnes J,
    4. et al.
    (2020) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease. Cochrane Database Syst Rev 7(7):CD013665, doi:10.1002/14651858.CD013665, pmid:http://www.ncbi.nlm.nih.gov/pubmed/32633856.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Ludvigsson JF
    (2020) Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr 109(6):1088–1095, doi:10.1111/apa.15270, pmid:http://www.ncbi.nlm.nih.gov/pubmed/32202343.
    OpenUrlCrossRefPubMed
  24. 24.
    1. Hu Y,
    2. Sun J,
    3. Dai Z,
    4. et al.
    (2020) Prevalence and severity of corona virus disease 2019 (COVID-19): a systematic review and meta-analysis. J Clin Virol 127:104371, doi:10.1016/j.jcv.2020.104371, pmid:http://www.ncbi.nlm.nih.gov/pubmed/32315817.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Zheng Z,
    2. Peng F,
    3. Xu B,
    4. et al.
    (2020) Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect 81(2):e16–e25, doi:10.1016/j.jinf.2020.04.021, pmid:32335169.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Cao Y,
    2. Liu X,
    3. Xiong L,
    4. Cai K
    (2020) Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis. J Med Virol 63(3), doi:10.1002/jmv.25822.
    OpenUrlCrossRef
  27. 27.
    1. Di Mascio D,
    2. Khalil A,
    3. Saccone G,
    4. et al.
    (2020) Outcome of coronavirus spectrum infections (SARS, MERS, COVID 1 -19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM 2(2):100107, doi:10.1016/j.ajogmf.2020.100107, pmid:http://www.ncbi.nlm.nih.gov/pubmed/32292902.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Fu L,
    2. Wang B,
    3. Yuan T,
    4. et al.
    (2020) Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis. J Infect 80(6):656–665, doi:10.1016/j.jinf.2020.03.041, pmid:http://www.ncbi.nlm.nih.gov/pubmed/32283155.
    OpenUrlCrossRefPubMed
  29. 29.
    1. Cheung KS,
    2. Hung IFN,
    3. Chan PPY,
    4. et al.
    (2020) Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis. Gastroenterology 159(1):81–95, doi:10.1053/j.gastro.2020.03.065, pmid:http://www.ncbi.nlm.nih.gov/pubmed/32251668.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Della Gatta AN,
    2. Rizzo R,
    3. Pilu G,
    4. et al.
    (2020) Coronavirus disease 2019 during pregnancy: a systematic review of reported cases. Am J Obstet Gynecol 223(1):36–41, doi:10.1016/j.ajog.2020.04.013, pmid:http://www.ncbi.nlm.nih.gov/pubmed/32311350.
    OpenUrlCrossRefPubMed
  31. 31.
    1. Castagnoli R,
    2. Votto M,
    3. Licari A,
    4. et al.
    (2020) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review. JAMA Pediatr doi:10.1001/jamapediatrics.2020.1467, pmid:http://www.ncbi.nlm.nih.gov/pubmed/32320004.
    OpenUrlCrossRefPubMed
  32. 32.
    1. Elshafeey F,
    2. Magdi R,
    3. Hindi N,
    4. et al.
    (2020) A systematic scoping review of COVID-19 during pregnancy and childbirth. Int J Gynaecol Obstet 150(1):47–52, doi:10.1002/ijgo.13182, pmid:http://www.ncbi.nlm.nih.gov/pubmed/32330287.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Rodriguez-Morales AJ,
    2. Cardona-Ospina JA,
    3. Gutiérrez-Ocampo E,
    4. et al.
    (2020) Latin American Network of Coronavirus Disease 2019-COVID-19 Research. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis 34, doi:10.1016/j.tmaid.2020.101623, pmid:32179124. 101623.
    OpenUrlCrossRefPubMed
  34. 34.
    1. Lovato A,
    2. de Filippis C
    (2020) Clinical presentation of COVID-19: a systematic review focusing on upper airway symptoms. Ear Nose Throat J doi:10.1177/0145561320920762, pmid:http://www.ncbi.nlm.nih.gov/pubmed/32283980. 145561320920762.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Asadi-Pooya AA,
    2. Simani L
    (2020) Central nervous system manifestations of COVID-19: a systematic review. J Neurol Sci 413, doi:10.1016/j.jns.2020.116832, pmid:http://www.ncbi.nlm.nih.gov/pubmed/32299017. 116832.
    OpenUrlCrossRefPubMed
  36. 36.↵
    1. de Souza TH,
    2. Nadal JA,
    3. Nogueira RJN,
    4. et al.
    (2020) Clinical manifestations of children with COVID-19: a systematic review. Pediatr Pulmonol 55(8):1892–1899, doi:10.1002/ppul.24885, pmid:http://www.ncbi.nlm.nih.gov/pubmed/32492251.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Parohan M,
    2. Yaghoubi S,
    3. Seraj A,
    4. et al.
    (2020; doi: 10.1101/2020.04.09.20056291) Risk factors for mortality in patients with coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. medRxiv.
  38. 38.
    1. Michelen M,
    2. Jones N,
    3. Stavropoulou C
    (2020) In patients of COVID-19, what are the symptoms and clinical features of mild and moderate cases? 13 Aug 2020. https://www.cebm.net/covid-19/in-patients-of-covid-19-what-are-the-symptoms-and-clinical-features-of-mild-and-moderate-case.
  39. 39.↵
    1. Burrow MR,
    2. Treadwell J,
    3. Roberts MN
    (2020) What clinical features or scoring system, if any, might best predict a benefit from hospital admission for patients with COVID-19? 13 Aug 2020. https://www.cebm.net/covid-19/what-clinical-features-or-scoring-system-if-any-might-best-predict-a-benefit-from-hospital-admission-for-patients-with-covid-19.
  40. 40.
    1. Khan MMA,
    2. Khan MN,
    3. Mustagir MG,
    4. et al.
    (2020) COVID-19 infection during pregnancy: a systematic review to summarize possible symptoms, treatments, and pregnancy outcomes. medRxiv.
  41. 41.
    1. Arabi S,
    2. Vaseghi G,
    3. Heidari Z,
    4. et al.
    (2020) Clinical characteristics of COVID-19 infection in pregnant women: a systematic review and meta-analysis. medRxiv.
  42. 42.↵
    1. Kahathuduwa CN,
    2. Dhanasekara CS,
    3. Chin S-H
    (2020) Case fatality rate in COVID-19: a systematic review and meta-analysis. medRxiv.
  43. 43.↵
    1. Xu L,
    2. Yaqian M,
    3. Chen G
    (2020) Risk factors for severe corona virus disease 2019 (COVID-19) patients : a systematic review and meta analysis. medRxiv.
  44. 44.
    1. Heydari K,
    2. Rismantab S,
    3. Shamshirian A,
    4. et al.
    (2020) Clinical and paraclinical characteristics of COVID-19 patients: a systematic review and meta-analysis. medRxiv.
  45. 45.↵
    1. Ebrahimi M,
    2. Saki A,
    3. Rahim F
    (2020) Laboratory findings, signs and symptoms, clinical outcomes of patients with COVID-19 infection: an updated systematic review and meta-analysis. medRxiv.
  46. 46.
    1. Ji W,
    2. Zhang J,
    3. Bishnu G,
    4. et al.
    (2020) Comparison of severe and non-severe COVID-19 pneumonia: review and meta-analysis. medRxiv.
  47. 47.↵
    1. Jain V,
    2. Yuan J-M
    (2020) Systematic review and meta-analysis of predictive symptoms and comorbidities for severe COVID-19 infection. medRxiv.
  48. 48.↵
    1. Greenhalgh T,
    2. Treadwell J,
    3. Burrow R,
    4. et al.
    (2020) NEWS (or NEWS2) score when assessing possible COVID-19 patients in primary care? 13 Aug 2020. https://www.cebm.net/covid-19/should-we-use-the-news-or-news2-score-when-assessing-patients-with-possible-covid-19-in-primary-care.
  49. 49.↵
    1. UK Sepsis Trust
    (2018) GP/ OOH telephone triage sepsis tool. 13 Aug 2020. https://sepsistrust.org/wp-content/uploads/2018/06/OOH-and-GP-telephone-triage-Adult-NICE-Final-3.pdf.
  50. 50.↵
    1. Royal College of General Practitioners
    (2020) COVID-19 evidence summary clinical management. 13 Aug 2020. https://elearning.rcgp.org.uk/mod/page/view.php?id=10570.
  51. 51.↵
    1. Vardavas CI,
    2. Nikitara K
    (2020) COVID-19 and smoking: a systematic review of the evidence. Tob Induc Dis 18, doi:10.18332/tid/119324, pmid:http://www.ncbi.nlm.nih.gov/pubmed/32206052. 20.
    OpenUrlCrossRefPubMed
  52. 52.
    1. Park M,
    2. Cook AR,
    3. Lim JT,
    4. et al.
    (2020) A systematic review of COVID-19 epidemiology based on current evidence. J Clin Med 9(4):967, doi:10.3390/jcm9040967.
    OpenUrlCrossRef
  53. 53.
    1. Chang T-H,
    2. Wu J-L,
    3. Chang L-Y
    (2020) Clinical characteristics and diagnostic challenges of pediatric COVID-19: a systematic review and meta-analysis. J Formos Med Assoc 119(5):982–989, doi:10.1016/j.jfma.2020.04.007, pmid:http://www.ncbi.nlm.nih.gov/pubmed/32307322.
    OpenUrlCrossRefPubMed
  54. 54.↵
    1. Minotti C,
    2. Tirelli F,
    3. Barbieri E,
    4. et al.
    (2020) How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review. J Infect 81(1):e61–e66, doi:10.1016/j.jinf.2020.04.026, pmid:http://www.ncbi.nlm.nih.gov/pubmed/32335173.
    OpenUrlCrossRefPubMed
  55. 55.↵
    1. Cohen JF,
    2. Korevaar DA,
    3. Matczak S,
    4. et al.
    (2020) COVID-19-related mortality by age groups in Europe: a meta-analysis. medRxiv.
  56. 56.
    1. Patanavanich R,
    2. Glantz SA
    (2020;) Smoking is associated with COVID-19 progression: a meta-analysis. Nicotine Tob Res doi:10.1093/ntr/ntaa082, pmid:32399563. ntaa082.
    OpenUrlCrossRefPubMed
  57. 57.↵
    1. Matsushita K,
    2. Ding N,
    3. Kou M,
    4. et al.
    (2020) The relationship of COVID-19 severity with cardiovascular disease and its traditional risk factors: a systematic review and meta-analysis. medRxiv.
  58. 58.
    1. Nasiri MJ,
    2. Haddadi S,
    3. Tahvildari A,
    4. et al.
    (2020) COVID-19 clinical characteristics, and sex-specific risk of mortality: systematic review and meta-analysis. medRxiv.
  59. 59.↵
    1. Zhao X,
    2. Zhang B,
    3. Li P,
    4. et al.
    (2020) Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis. medRxiv.
  60. 60.↵
    1. Alqahtani JS,
    2. Oyelade T,
    3. Aldhahir AM,
    4. et al.
    (2020) Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. PLoS One 15(5), doi:10.1371/journal.pone.0233147, pmid:http://www.ncbi.nlm.nih.gov/pubmed/32392262. e0233147.
    OpenUrlCrossRefPubMed
  61. 61.↵
    1. Russell B,
    2. Moss C,
    3. George G,
    4. et al.
    (2020) Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence. Ecancermedicalscience 14, doi:10.3332/ecancer.2020.1022, pmid:http://www.ncbi.nlm.nih.gov/pubmed/32256705. 1022.
    OpenUrlCrossRefPubMed
  62. 62.
    1. Wang B,
    2. Li R,
    3. Lu Z,
    4. Huang Y
    (2020) Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging 12(7).
  63. 63.
    1. Emami A,
    2. Javanmardi F,
    3. Pirbonyeh N,
    4. et al.
    (2020) Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Arch Acad Emerg Med 8(1):e35.
    OpenUrlPubMed
  64. 64.
    1. Zuin M,
    2. Rigatelli G,
    3. Zuliani G,
    4. et al.
    (2020) Arterial hypertension and risk of death in patients with COVID-19 infection: systematic review and meta-analysis. J Infect 81(1):e84–e86, doi:10.1016/j.jinf.2020.03.059, pmid:http://www.ncbi.nlm.nih.gov/pubmed/32283158.
    OpenUrlCrossRefPubMed
  65. 65.
    1. Yang J,
    2. Zheng Y,
    3. Gou X,
    4. et al.
    (2020) Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis 94:91–95, doi:10.1016/j.ijid.2020.03.017, pmid:http://www.ncbi.nlm.nih.gov/pubmed/32173574.
    OpenUrlCrossRefPubMed
  66. 66.↵
    1. Huang I,
    2. Lim MA,
    3. Pranata R
    (2020) Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia — a systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr 14(4):395–403, doi:10.1016/j.dsx.2020.04.018, pmid:32334395.
    OpenUrlCrossRefPubMed
  67. 67.↵
    1. Shamshirian A,
    2. Heydari K,
    3. Alizadeh-Navaei R,
    4. et al.
    (2020) Cardiovascular diseases burden in COVID-19: systematic review and meta-analysis. medRxiv, 20062869.
  68. 68.↵
    1. Chen Y,
    2. Gong X,
    3. Wang L,
    4. et al.
    (2020) Effects of hypertension, diabetes and coronary heart disease on COVID-19 diseases severity: a systematic review and meta-analysis. medRxiv.
  69. 69.↵
    1. Public Health England
    (2020) Guidance on shielding and protecting people who are clinically extremely vulnerable from COVID-19. 13 Aug 2020. https://www.gov.uk/government/publications/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19.
  70. 70.↵
    1. Health Protection Scotland
    (2020) Search criteria for highest risk patients for shielding. 13 Aug 2020. https://hpspubsrepo.blob.core.windows.net/hps-website/nss/3008/documents/1_covid-19-search-criteria-highest-risk-patients.pdf.
  71. 71.↵
    1. Mair FS,
    2. May C,
    3. O'Donnell C,
    4. et al.
    (2012) Factors that promote or inhibit the implementation of e-health systems: an explanatory systematic review. Bull World Health Organ 90(5):357–364, doi:10.2471/BLT.11.099424, pmid:http://www.ncbi.nlm.nih.gov/pubmed/22589569.
    OpenUrlCrossRefPubMed
  72. 72.↵
    1. Sheikh A,
    2. Cornford T,
    3. Barber N,
    4. et al.
    (2011) Implementation and adoption of nationwide electronic health records in secondary care in England: final qualitative results from prospective national evaluation in "early adopter" hospitals. BMJ 343, doi:10.1136/bmj.d6054, pmid:http://www.ncbi.nlm.nih.gov/pubmed/22006942. d6054.
    OpenUrlAbstract/FREE Full Text
  73. 73.↵
    1. Bouamrane M-M,
    2. Mair FS
    (2013) A study of general practitioners' perspectives on electronic medical records systems in NHSScotland. BMC Med Inform Decis Mak 13, doi:10.1186/1472-6947-13-58, pmid:http://www.ncbi.nlm.nih.gov/pubmed/23688255. 58.
    OpenUrlCrossRefPubMed
  74. 74.↵
    1. Kazmi Z
    (2013) Effects of exam room EHR use on doctor-patient communication: a systematic literature review. Inform Prim Care 21(1):30–39, doi:10.14236/jhi.v21i1.37, pmid:http://www.ncbi.nlm.nih.gov/pubmed/24629654.
    OpenUrlCrossRefPubMed
  75. 75.↵
    1. Mann C,
    2. Shaw A,
    3. Wye L,
    4. et al.
    (2018) A computer template to enhance patient-centredness in multimorbidity reviews: a qualitative evaluation in primary care. Br J Gen Pract 68(672):e495–e504, doi:10.3399/bjgp18X696353, pmid:http://www.ncbi.nlm.nih.gov/pubmed/29784866.
    OpenUrlAbstract/FREE Full Text
  76. 76.↵
    1. de Lusignan S,
    2. Dorward J,
    3. Correa A,
    4. et al.
    (2020) Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study. Lancet Infect Dis doi:10.1016/S1473-3099(20)30371-6, pmid:32422204.
    OpenUrlCrossRefPubMed
  77. 77.↵
    1. Williamson E,
    2. Walker AJ,
    3. Bhaskaran KJ
    (2020) The OpenSAFELY Collaborative. OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients. medRxiv.
  78. 78.↵
    1. Cahan A,
    2. Cimino JJ
    (2017) A learning health care system using computer-aided diagnosis. J Med Internet Res 19(3), doi:10.2196/jmir.6663, pmid:http://www.ncbi.nlm.nih.gov/pubmed/28274905. e54.
    OpenUrlCrossRefPubMed
  79. 79.↵
    1. BioPortal
    (2020) COVID-19 surveillance ontology. 13 Aug 2020. https://bioportal.bioontology.org/ontologies/COVID19/?p=summary.
  80. 80.↵
    1. NHS Digital
    (2020) COVID-19 SNOMED CT codes by groups 20200401v1.0. 13 Aug 2020. https://hscic.kahootz.com/connect.ti/COVID19_info_sharing/view?objectId=67227941.
  81. 81.↵
    1. Andrews JE,
    2. Patrick TB,
    3. Richesson RL,
    4. et al.
    (2008) Comparing heterogeneous SNOMED CT coding of clinical research concepts by examining normalized expressions. J Biomed Inform 41(6):1062–1069, doi:10.1016/j.jbi.2008.01.010, pmid:http://www.ncbi.nlm.nih.gov/pubmed/18328789.
    OpenUrlCrossRefPubMed
  82. 82.↵
    1. Andrews JE,
    2. Richesson RL,
    3. Krischer J
    (2007) Variation of SNOMED CT coding of clinical research concepts among coding experts. J Am Med Inform Assoc 14(4):497–506, doi:10.1197/jamia.M2372, pmid:http://www.ncbi.nlm.nih.gov/pubmed/17460128.
    OpenUrlCrossRefPubMed
Back to top

In this issue

BJGP Open
Vol. 4, Issue 4
October 2020
Download PDF
Download PowerPoint
Email Article
Citation Tools
Recording COVID-19 consultations: review of symptoms, risk factors, and proposed SNOMED CT terms
Bhautesh Dinesh Jani, Jill P Pell, Dylan McGagh, Harshana Liyanage, Dave Kelly, Simon de Lusignan, Christopher J Weatherburn, Ronnie Burns, Frank M Sullivan, Frances S Mair
BJGP Open 2020; 4 (4): bjgpopen20X101125. DOI: 10.3399/bjgpopen20X101125
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section

Keywords

Intended for Healthcare Professionals

 
 

British Journal of General Practice